
The European Society of Cardiology (ESC) has issued its inaugural comprehensive global guidelines on cardiomyopathies, marking a significant milestone in the field of heart muscle dysfunction diagnosis and treatment. The guidelines were presented during the ESC Congress 2023 and are now accessible in the European Heart Journal. Guidelines encompass all cardiomyopathy subtypes, breaking new ground by offering specific recommendations for non-hypertrophic cardiomyopathies. The guidelines also highlight the critical role of cardiovascular magnetic resonance (CMR) imaging and genetic testing in the diagnostic process.
Like
Save
Share